Dr. Slawin’s address, “Building on the Foundation of Four: Advancing Mitochondrial‑Targeted Geropeptide Medicine” will directly follow Dr. Hazel H. Szeto’s historic keynote address, “From Mitochondrial Discovery to Approved Therapy: Lessons for the Future of Medicine”
that is scheduled to open the conference.
For more about the congress:
